Compare GNTA & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNTA | PNI |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 76.9M |
| IPO Year | 2021 | N/A |
| Metric | GNTA | PNI |
|---|---|---|
| Price | $1.42 | $6.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 122.9K | 26.4K |
| Earning Date | 03-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.76% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.28 | $6.03 |
| 52 Week High | $10.00 | $7.89 |
| Indicator | GNTA | PNI |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 47.01 |
| Support Level | $1.28 | $6.82 |
| Resistance Level | $1.77 | $6.97 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 22.78 | 47.02 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.